139 related articles for article (PubMed ID: 20019240)
1. Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.
Jeong BS; Hu W; Belyi V; Rabadan R; Levine AJ
FASEB J; 2010 May; 24(5):1347-53. PubMed ID: 20019240
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
3. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
4. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
[TBL] [Abstract][Full Text] [Related]
5. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
6. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
7. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.
Schneider-Stock R; Mawrin C; Motsch C; Boltze C; Peters B; Hartig R; Buhtz P; Giers A; Rohrbeck A; Freigang B; Roessner A
Am J Pathol; 2004 Apr; 164(4):1233-41. PubMed ID: 15039212
[TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Papadakis EN; Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
[TBL] [Abstract][Full Text] [Related]
9. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
[TBL] [Abstract][Full Text] [Related]
10. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
Dumont P; Leu JI; Della Pietra AC; George DL; Murphy M
Nat Genet; 2003 Mar; 33(3):357-65. PubMed ID: 12567188
[TBL] [Abstract][Full Text] [Related]
11. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Bonafé M; Ceccarelli C; Farabegoli F; Santini D; Taffurelli M; Barbi C; Marzi E; Trapassi C; Storci G; Olivieri F; Franceschi C
Clin Cancer Res; 2003 Oct; 9(13):4860-4. PubMed ID: 14581358
[TBL] [Abstract][Full Text] [Related]
12. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
Zhu J; Jiang J; Zhou W; Zhu K; Chen X
Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
[TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
[TBL] [Abstract][Full Text] [Related]
15. Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients.
Acharya M; Mitra S; Mukhopadhyay A; Khan M; Roychoudhury S; Ray K
Mol Vis; 2002 Sep; 8():367-71. PubMed ID: 12368717
[TBL] [Abstract][Full Text] [Related]
16. The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia.
Sansone P; Storci G; Pandolfi S; Montanaro L; Chieco P; Bonafé M
Br J Cancer; 2007 Apr; 96(8):1302-8. PubMed ID: 17406354
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma.
Tsai MH; Lin CD; Hsieh YY; Chang FC; Tsai FJ; Chen WC; Tsai CH
Laryngoscope; 2002 Jan; 112(1):116-9. PubMed ID: 11802048
[TBL] [Abstract][Full Text] [Related]
18. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of tumor protein p53 codon 72 showed no association with oral lichen planus in Shiraz, Iran.
Ghabanchi J; Fattahi MJ; Mardani M; Tadbir AA; Paydar AA
J Craniofac Surg; 2009 Nov; 20(6):2168-70. PubMed ID: 19884837
[TBL] [Abstract][Full Text] [Related]
20. P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the chinese.
Wang NM; Tsai CH; Yeh KT; Chen SJ; Chang JG
Int J Mol Med; 1999 Sep; 4(3):249-52. PubMed ID: 10425273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
